Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers
Hugosson, Jonas ; Lilja, Hans LU
; Lodding, Pär
and Pihl, Carl Gustav
(2001)
In European Urology
39(Suppl 4).
p.33-34
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1121912
- author
- Hugosson, Jonas
; Lilja, Hans
LU
; Lodding, Pär
and Pihl, Carl Gustav
- organization
- publishing date
- 2001
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Urology
- volume
- 39
- issue
- Suppl 4
- pages
- 33 - 34
- publisher
- Elsevier
- external identifiers
-
- pmid:11340286
- scopus:0035012442
- ISSN
- 1873-7560
- DOI
- 10.1159/000052582
- language
- English
- LU publication?
- yes
- id
- d639e3c5-e52e-4282-9c89-ef34bfb48380 (old id 1121912)
- date added to LUP
- 2016-04-01 15:23:37
- date last changed
- 2022-03-22 04:12:21
@article{d639e3c5-e52e-4282-9c89-ef34bfb48380,
author = {{Hugosson, Jonas and Lilja, Hans and Lodding, Pär and Pihl, Carl Gustav}},
issn = {{1873-7560}},
language = {{eng}},
number = {{Suppl 4}},
pages = {{33--34}},
publisher = {{Elsevier}},
series = {{European Urology}},
title = {{Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers}},
url = {{http://dx.doi.org/10.1159/000052582}},
doi = {{10.1159/000052582}},
volume = {{39}},
year = {{2001}},
}